#USA #pharmaceuticals #Pleasanton #Biogen #Veeva Vault CRM

Biogen Chooses Veeva Vault CRM

Biogen, a leading biotechnology company dedicated to the development of innovative medicines to treat neurological diseases, has officially announced its decision to adopt Veeva Vault CRM as part of its global operations. This strategic partnership cements Veeva's position as a foundational component in Biogen's commitment to delivering effective and life-transforming therapies to patients around the world.

Tom Schwenger, President and Chief Commercial Officer of Veeva, expressed the importance of this collaboration, stating, "We are honored to provide Vault CRM as the strategic commercial foundation for Biogen in their mission to offer medicines that transform patients’ lives." This emphasis on patient-centric solutions underscores the growing need for adaptability in commercial strategies, particularly in industries as complex as biotechnology and pharmaceuticals.

The adoption of Vault CRM signifies a shift towards more sophisticated capabilities that aim to enhance the impact of treatments in the market. Schwenger noted, "Bringing complex therapies to market requires a highly adaptive commercial strategy, and we are committed to providing the advanced capabilities needed to accelerate patient impact globally."

Biogen's Senior Vice President and Global Chief Information Officer, Guy Hadari, commented on the integration of Veeva's solutions, highlighting the shared dedication between the two companies towards customer experience and innovation. Hadari remarked, "We are excited to expand our strategic alliance with Veeva through the migration to Vault CRM." This statement highlights the proactive approach Biogen is taking to ensure its commercial strategies are not only effective but also innovative and aligned with customer needs.

The Veeva Vault CRM includes essential tools such as Agent Call Reporting which is tailored to generate commercial evidence, helping sales representatives engage more effectively with healthcare professionals. The suite of applications within Vault CRM represents a new commercial model that leverages artificial intelligence to ensure that appropriate medications reach a broader audience of patients.

About Veeva Systems

Veeva Systems is recognized as the leading cloud platform within the life sciences sector, offering a range of applications designed to enhance the efficiency of commercial operations. With a commitment to innovation and excellence, Veeva has successfully partnered with over 1,500 clients, ranging from large pharmaceutical companies to emerging biotech firms. Veeva’s platform is designed to balance the interests of all stakeholders, including customers, employees, shareholders, and the communities they serve.

For more information about Veeva Systems and their offerings, visit veeva.com.

Looking Forward

The alliance between Biogen and Veeva Systems exemplifies the integration of technology and strategic planning in the life sciences industry. As both companies continue their collaboration, the hope is to create more efficacious, accessible treatments that can significantly improve patient outcomes across the globe. This partnership not only highlights Biogen's commitment to advancing healthcare solutions but also Veeva’s pivotal role in shaping the future of biotechnology through innovative technology. As developments unfold, industry professionals and stakeholders will closely monitor how these advancements translate into real-world impacts for patients in need.